Your browser doesn't support javascript.
loading
Cardiac involvement in female carriers of duchenne or becker muscular dystrophy.
Mccaffrey, Thomas; Guglieri, Michela; Murphy, Alexander P; Bushby, Katherine; Johnson, Anna; Bourke, John P.
Afiliação
  • Mccaffrey T; The John Walton, Muscular Dystrophy Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Guglieri M; Department of Cardiology, Freeman Hospital, Newcastle upon Tyne NHS Hospitals Foundation Trust, NE7 7DN, United Kingdom.
  • Murphy AP; The John Walton, Muscular Dystrophy Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Bushby K; The John Walton, Muscular Dystrophy Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Johnson A; The John Walton, Muscular Dystrophy Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Bourke JP; The John Walton, Muscular Dystrophy Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Muscle Nerve ; 55(6): 810-818, 2017 06.
Article em En | MEDLINE | ID: mdl-27761893
ABSTRACT

INTRODUCTION:

The significance of abnormal cardiac measures in asymptomatic females who harbor dystrophin gene mutations is controversial.

METHODS:

Echo-measures of ventricular function were compared with published norms in a cross-sectional study of 130 (age, 39 ± 15.7 years) "carriers" of Duchenne or Becker muscular dystrophy (DMD/BMD). Correlations between cardiomyopathy (CM) and mutation, creatine kinase (CK) levels, age, and muscle symptoms were investigated.

RESULTS:

Depending on definition, CM prevalence was 3-33%. Ejection fraction (Simpson method) was < 55% in 9 (13%) and < 40% in 2 (2.9%). Eleven (8.5%) had wall motion abnormalities. Left ventricular end-systolic dimensions were increased in 7 (5.7%) and end-diastolic in 17 (13.9%). CM did not correlate with mutation type, DMD or BMD phenotype, CK level, muscle symptoms, or age.

CONCLUSIONS:

Occult CM can be found by screening in DMD/BMD carriers. Its lack of age-correlation suggests that not all abnormalities progress. Optimum screening schedules require a better understanding of progressive CM. Muscle Nerve 55 810-818, 2017.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distrofina / Distrofias Musculares / Mutação / Cardiomiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Muscle Nerve Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Distrofina / Distrofias Musculares / Mutação / Cardiomiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Muscle Nerve Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido